Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|
May 10, 2021
[Research Progress in Hepatocyte Growth Factor/Mesenchymal-epithelial Transition Factor Signaling Pathway:Effects and Mechanisms on Resistance to Targeted Therapy for Non-small Cell Lung Cancer]
Heng Yi Chen, Yong He
Immunological Reviews
|
November 25, 2021
Micro but mighty-Micronutrients in the epigenetic regulation of adaptive immune responses
Heng-Yi Chen, Michael Hsu, Chan-Wang Jerry Lio
International Journal of Molecular Sciences
|
February 2, 2018
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou, Heng-Yi Chen, Chih-Chi Kuo, et al.
Journal of Diabetes Research
|
May 15, 2013
Rodent models for investigating the dysregulation of immune responses in type 1 diabetes
Feng-Cheng Chou, Heng-Yi Chen, Shyi-Jou Chen, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
MNase stratification reveals heterogeneous 5hmC in naive B cells
Michael Hsu, Heng-Yi Chen, Fang-Yun Lay, et al.
Clinical Lung Cancer
|
January 10, 2017
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer
Kun-Lin Li, Li Li, Peng Zhang, et al.
Diabetologia
|
September 21, 2017
Differential modulation of IL-12 family cytokines in autoimmune islet graft failure in mice
Feng-Cheng Chou, Heng-Yi Chen, Hsin-Hui Chen, et al.
Oncology Letters
|
July 3, 2015
Efficacy of recombinant adenoviral human p53 gene in the treatment of lung cancer-mediated pleural effusion
Kun-Lin Li, Jun Kang, Peng Zhang, et al.
The Clinical Respiratory Journal
|
October 12, 2018
Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling
Yong-Hong Pan, Cai-Yu Lin, Cong-Hua Lu, et al.
Biologics : Targets & Therapy
|
August 30, 2018
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
Yong-Hong Pan, Lin Jiao, Cai-Yu Lin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|
May 10, 2021
[Research Progress in Hepatocyte Growth Factor/Mesenchymal-epithelial Transition Factor Signaling Pathway:Effects and Mechanisms on Resistance to Targeted Therapy for Non-small Cell Lung Cancer]
Heng Yi Chen, Yong He
Immunological Reviews
|
November 25, 2021
Micro but mighty-Micronutrients in the epigenetic regulation of adaptive immune responses
Heng-Yi Chen, Michael Hsu, Chan-Wang Jerry Lio
International Journal of Molecular Sciences
|
February 2, 2018
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou, Heng-Yi Chen, Chih-Chi Kuo, et al.
Journal of Diabetes Research
|
May 15, 2013
Rodent models for investigating the dysregulation of immune responses in type 1 diabetes
Feng-Cheng Chou, Heng-Yi Chen, Shyi-Jou Chen, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
MNase stratification reveals heterogeneous 5hmC in naive B cells
Michael Hsu, Heng-Yi Chen, Fang-Yun Lay, et al.
Clinical Lung Cancer
|
January 10, 2017
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer
Kun-Lin Li, Li Li, Peng Zhang, et al.
Diabetologia
|
September 21, 2017
Differential modulation of IL-12 family cytokines in autoimmune islet graft failure in mice
Feng-Cheng Chou, Heng-Yi Chen, Hsin-Hui Chen, et al.
Oncology Letters
|
July 3, 2015
Efficacy of recombinant adenoviral human p53 gene in the treatment of lung cancer-mediated pleural effusion
Kun-Lin Li, Jun Kang, Peng Zhang, et al.
The Clinical Respiratory Journal
|
October 12, 2018
Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling
Yong-Hong Pan, Cai-Yu Lin, Cong-Hua Lu, et al.
Biologics : Targets & Therapy
|
August 30, 2018
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
Yong-Hong Pan, Lin Jiao, Cai-Yu Lin, et al.
Page
of 2